Our Chief Financial Officer and Chief Corporate Development Officer, has nearly two decades of experience working in the private equity and venture capital industries as both an investor and executive. From January 2019 to December 2019, Mr. Isaacson served as the Chief Financial Officer of Senseonics, Inc. (NYSE: SENS), a portfolio company of venture capital firm New Enterprise Associates, and provided advisory services to Senseionics from January 2020 to June 2020. Prior to joining Senseonics, he served as the Chief Financial Officer of Edelman Financial Services, LLC from November 2017 to December 2018.

Before joining Edelman Financial Services, he served as a Managing Director for over 14 years at American Capital, Ltd from November 2002 to January 2017. Mr. Isaacson also held roles at Thayer Capital Partners, L.P., GTCR LLC, McKinsey & Company and Morgan Stanley & Co., LLC. He served as a director of each of ECA Medical Instruments, The Meadows and Alchemy Corporation from 2014 to 2016, where he served on the compensation and audit committees of each.